Pharmac have released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a standard Special Authority.
Please follow this link to read the proposal and recommended changes to the Special Authority for access.
Your Feedback is Important
Pharmac is seeking feedback on this proposal.
Consultation closes 4pm Friday 18 December and feedback can be emailed to email@example.com.
Alternatively Multiple Sclerosis NZ are seeking testimonials from people who will be impacted by the proposed changes to include in our submission. If you would like to be included in this please send your testamonial to firstname.lastname@example.org. Thank you.
Please feel free to circulate this to others who may be interested.